PPARA and non-small cell lung carcinoma: The ligand activation of PPARα inhibited the formation of proangiogenic epoxyeicosatrienoic acids (EET) by the cytochrome P450 arachidonic acid epoxygenases (Cyp2c), and thereby reduced NSCLC growth and metastatic progression in vivo [65,247].